All Moods

90% Felt it uplift their spirit with an instantaneous mood lift.
88% Experienced a sense of contentment.
80% Felt invigorated and experienced a reduction in negative emotions.

*Consumer Trial: Euphoric was tested in a two-week consumer user trial with 50 healthy adults, ages 18-60.

25% Immediate reduction in stress levels, and increased calmness.
10% Decrease in blood pressure, with a 30% faster return to baseline.
10% Reduction in stress-related immune and hormone responses.

*Clinical Trial: Chill was tested in a clinical study trial on 90 healthy adults where participants completed validated multi-tasking framework designed to induce acute stress, simulating the cognitive overload of a busy workday or high-pressure environment.

25% Immediate reduction in stress levels, and increased calmness.
10% Decrease in blood pressure, with a 30% faster return to baseline.
10% Reduction in stress-related immune and hormone responses.

*Clinical Trial: Chill was tested in a clinical study trial on 90 healthy adults where participants completed validated multi-tasking framework designed to induce acute stress, simulating the cognitive overload of a busy workday or high-pressure environment.

30% Reduction in social anxiety, such as in high-pressure situations.
25% Decrease in cortisol levels - stress hormone.
25% Calmer heart rate during stressful events.

*Clinical Trial: Charisma was tested in a clinical study trial on 150 healthy adults using the Trier Social Stress Test (TSST) to assess its impact on social anxiety.

30% Increase in brain function and cognitive performance.
25% Boost in alertness and reduction of fatigue.
15% Increase in test accuracy for long-term memory.

*Clinical Trial: Genius was tested in a clinical study trial on 90 healthy adults where participants completed cognitive performance tests measuring memory, attention, and executive function.

82% Felt more positive and high-spirited.
76% Felt more cheerful and playful.
69% Noticed an enhanced carefree attitude and a frisky feeling.

*Consumer Trial: Frisky was tested in a two-week consumer user trial with 50 healthy adults, ages 18-60.

76% Agreed it positively impacted their mood and feeling balanced.
73% Reported improved mindfulness and sense of being centred.
69% Noticed reduced anxiety and tension.

*Consumer Trial: Found was tested in a two-week consumer user trial with 50 healthy adults, ages 18-60.

Genius:
30% Increase in brain function and cognitive performance.
25% Boost in alertness and reduction of fatigue.
15% Increase in test accuracy for long-term memory.

Fit:
90% Felt more awake and alert after use.
88% Experienced relief from congestion or feeling unwell.
86% Reported improved focus and readiness to take on the day.

Chill:
25% Immediate reduction in stress levels, and increased calmness.
10% Decrease in blood pressure, with a 30% faster return to baseline.
10% Reduction in stress-related immune and hormone responses.

Found:
76% Agreed it positively impacted their mood and feeling balanced.
73% Reported improved mindfulness and sense of being centred.
69% Noticed reduced anxiety and tension.

90% Felt more awake and alert after use.
88% Experienced relief from congestion or feeling unwell.
86% Reported improved focus and readiness to take on the day.

*Consumer Trial: Fit was tested in a two-week consumer user trial with 50 healthy adults, ages 18-60.

Euphoric:
90% Felt it uplift their spirit with an instantaneous mood lift.
88% Felt more cheerful and playful.
80% Felt invigorated and experienced a reduction in negative emotions.

Hustle:
35% Improvement in brain signal strength related to attention and cognitive processing.
10% Increase in attention accuracy.
5% Faster reaction time.

35% Improvement in brain signal strength related to attention and cognitive processing.
10% Increase in accuracy for attention-based tasks
5% Boost in cognitive processing speed, improving reaction time.

*Clinical Trial: Hustle was tested in a clinical study trial on 90 healthy adults where participants completed a series on neurocognitive tests to assess impact on focus, reaction speed, and cognitive processing through EEG brainwave activity.

Charisma:
30% Reduction in social anxiety, such as in high-pressure situations.
25% Decrease in cortisol levels - stress hormone.
25% Calmer heart rate during stressful events.

Frisky:
82% Felt more positive and high-spirited.
76% Felt more cheerful and playful.
69% Noticed an enhanced carefree attitude and a frisky feeling.

76% Agreed it positively impacted their mood and feeling balanced.
73% Reported improved mindfulness and sense of being centred.
69% Noticed reduced anxiety and tension.

*Consumer Trial: Found was tested in a two-week consumer user trial with 50 healthy adults, ages 18-60.

30% Reduction in social anxiety, such as in high-pressure situations.
25% Decrease in cortisol levels - stress hormone.
25% Calmer heart rate during stressful events.

*Clinical Trial: Charisma was tested in a clinical study trial on 150 healthy adults using the Trier Social Stress Test (TSST) to assess its impact on social anxiety.

90% Felt it uplift their spirit with an instantaneous mood lift.
88% Experienced a sense of contentment.
80% Felt invigorated and experienced a reduction in negative emotions.

*Consumer Trial: Euphoric was tested in a two-week consumer user trial with 50 healthy adults, ages 18-60.

82% Felt more positive and high-spirited.
76% Felt more cheerful and playful.
69% Noticed an enhanced carefree attitude and a frisky feeling.

*Consumer Trial: Frisky was tested in a two-week consumer user trial with 50 healthy adults, ages 18-60.

90% Felt more awake and alert after use.
88% Experienced relief from congestion or feeling unwell.
86% Reported improved focus and readiness to take on the day.

*Consumer Trial: Fit was tested in a two-week consumer user trial with 50 healthy adults, ages 18-60.

CHILL (Clinically-Proven)

25% Immediate reduction in stress levels, and increased calmness.
10% Decrease in blood pressure, with a 30% faster return to baseline.
10% Reduction in stress-related immune and hormone responses.

*Clinical Trial: Chill was tested in a clinical study trial on 90 healthy adults where participants completed validated multi-tasking framework designed to induce acute stress, simulating the cognitive overload of a busy workday or high-pressure environment.

FIT

90% Felt more awake and alert after use.
88% Experienced relief from congestion or feeling unwell.
86% Reported improved focus and readiness to take on the day.

*Consumer Trial: Fit was tested in a two-week consumer user trial with 50 healthy adults, ages 18-60.

90% Felt it uplift their spirit with an instantaneous mood lift.
88% Felt more cheerful and playful.
80% Felt invigorated and experienced a reduction in negative emotions.

*Consumer Trial: Euphoric was tested in a two-week consumer user trial with 50 healthy adults, ages 18-60.

25% Immediate reduction in stress levels, and increased calmness.
10% Decrease in blood pressure, with a 30% faster return to baseline.
10% Reduction in stress-related immune and hormone responses.

*Clinical Trial: Chill was tested in a clinical study trial on 90 healthy adults where participants completed validated multi-tasking framework designed to induce acute stress, simulating the cognitive overload of a busy workday or high-pressure environment.

CHARISMA (Clinically-Proven)

30% Reduction in social anxiety, such as in high-pressure situations.
25% Decrease in cortisol levels - stress hormone.
25% Calmer heart rate during stressful events.

*Clinical Trial: Charisma was tested in a clinical study trial on 150 healthy adults using the Trier Social Stress Test (TSST) to assess its impact on social anxiety.

30% Increase in brain function and cognitive performance.
25% Boost in alertness and reduction of fatigue.
15% Increase in test accuracy for long-term memory.

*Clinical Trial: Genius was tested in a clinical study trial on 90 healthy adults where participants completed cognitive performance tests measuring memory, attention, and executive function.

35% Improvement in brain signal strength related to attention and cognitive processing.
10% Increase in accuracy for attention-based tasks.
5% Boost in cognitive processing speed, improving reaction time.

*Clinical Trial: Hustle was tested in a clinical study trial on 90 healthy adults where participants completed a series on neurocognitive tests to assess impact on focus, reaction speed, and cognitive processing through EEG brainwave activity.

76% Agreed it positively impacted their mood and feeling balanced.
73% Reported improved mindfulness and sense of being centred.
69% Noticed reduced anxiety and tension.

*Consumer Trial: Found was tested in a two-week consumer user trial with 50 healthy adults, ages 18-60.

90% Felt more awake and alert after use.
88% Experienced relief from congestion or feeling unwell.
86% Reported improved focus and readiness to take on the day.

*Consumer Trial: Fit was tested in a two-week consumer user trial with 50 healthy adults, ages 18-60.

GENIUS (Clinically-Proven)

30% Increase in brain function and cognitive performance.
25% Boost in alertness and reduction of fatigue.
15% Increase in test accuracy for long-term memory.

*Clinical Trial: Genius was tested in a clinical study trial on 90 healthy adults where participants completed cognitive performance tests measuring memory, attention, and executive function.

FOUND

76% Agreed it positively impacted their mood and feeling balanced.
73% Reported improved mindfulness and sense of being centred.
69% Noticed reduced anxiety and tension.

*Consumer Trial: Found was tested in a two-week consumer user trial with 50 healthy adults, ages 18-60.

FRISKY

82% Felt more positive and high-spirited.
76% Felt more cheerful and playful.
69% Noticed an enhanced carefree attitude and a frisky feeling.

*Consumer Trial: Frisky was tested in a two-week consumer user trial with 50 healthy adults, ages 18-60.

EUPHORIC

90% Felt it uplift their spirit with an instantaneous mood lift.
88% Experienced a sense of contentment.
80% Felt invigorated and experienced a reduction in negative emotions.

*Consumer Trial: Euphoric was tested in a two-week consumer user trial with 50 healthy adults, ages 18-60.

HUSTLE (Clinically-Proven)

35% Improvement in brain signal strength related to attention and cognitive processing.
10% Increase in accuracy for attention-based tasks
5% Boost in cognitive processing speed, improving reaction time.

*Clinical Trial: Hustle was tested in a clinical study trial on 90 healthy adults where participants completed a series on neurocognitive tests to assess impact on focus, reaction speed, and cognitive processing through EEG brainwave activity.